Search - tctmd.com

Displaying 1 - 20 of 48

Sort: Relevancy | Date

DECAF: Daily Coffee, Not Abstinence, Beneficial for AF Patients

News Conference News AHA 2025

DECAF: Daily Coffee, Not Abstinence, Beneficial for AF Patients

Michael O'Riordan

November 09, 2025

BEAT PAROX-AF: Pulsed-Field Ablation Not Superior to Radiofrequency

News Conference News ESC 2025

BEAT PAROX-AF: Pulsed-Field Ablation Not Superior to Radiofrequency

September 09, 2025

Treatment Based on ABC-AF Risk Scores Doesn’t Improve AF Outcomes

News Conference News ESC 2025

Treatment Based on ABC-AF Risk Scores Doesn’t Improve AF Outcomes

September 08, 2025

High Residual Risk of Recurrent Stroke Seen in AF Patients on Anticoagulants

News Conference News ESOC 2025

High Residual Risk of Recurrent Stroke Seen in AF Patients on Anticoagulants

May 29, 2025

GLP-1 Drugs May Have Role in Secondary Prevention of AF

News Conference News HRS 2025

GLP-1 Drugs May Have Role in Secondary Prevention of AF

April 28, 2025

SWISS-APERO at 3 Years: Hints of Differences Between Amulet, Watchman Emerge

News Conference News EHRA 2025

SWISS-APERO at 3 Years: Hints of Differences Between Amulet, Watchman Emerge

April 09, 2025

Pulsed-Field Ablation Equals, and May Top, Cryoablation for Paroxysmal AF

News Conference News EHRA 2025

Pulsed-Field Ablation Equals, and May Top, Cryoablation for Paroxysmal AF

March 31, 2025

Lifestyle and Risk Factors Matter for AF Burden—Metformin May Not: TRIM-AF

News Conference News AHA 2024

Lifestyle and Risk Factors Matter for AF Burden—Metformin May Not: TRIM-AF

November 18, 2024

Rivaroxaban Doesn’t Cut Cognitive Decline, Stroke, or TIA in Younger AF Patients

News Conference News AHA 2024

Rivaroxaban Doesn’t Cut Cognitive Decline, Stroke, or TIA in Younger AF Patients

November 16, 2024

LAAO Outcomes Similar Regardless of Operator’s Specialty

News Conference News TCT 2024

LAAO Outcomes Similar Regardless of Operator’s Specialty

October 27, 2024

EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER

News Conference News HFSA 2024

EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER

October 03, 2024

Edoxaban Monotherapy Wins for AF and Stable Coronary Disease: EPIC-CAD

News Conference News ESC 2024

Edoxaban Monotherapy Wins for AF and Stable Coronary Disease: EPIC-CAD

September 01, 2024

CASA-AF: Similar 3-Year Efficacy for Surgical and Catheter Ablation

News Conference News HRS 2024

CASA-AF: Similar 3-Year Efficacy for Surgical and Catheter Ablation

May 23, 2024

AZALEA-TIMI 71: Abelacimab Slashes Bleeds vs Rivaroxaban in AF, but Stroke Impact Unclear

News Conference News AHA 2023

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

November 12, 2023

ARTESiA: Apixaban Lowers Stroke Risk in Subclinical AF

News Conference News AHA 2023

ARTESiA: Apixaban Lowers Stroke Risk in Subclinical AF

November 12, 2023

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

News Conference News TCT 2023

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

October 24, 2023

DANPACE II: Reducing Atrial Pacing Doesn’t Prevent AF in Sinus Node Disease

News Conference News ESC 2023

DANPACE II: Reducing Atrial Pacing Doesn’t Prevent AF in Sinus Node Disease

August 30, 2023

ADVENT: Pulsed-Field Ablation for Paroxysmal AF Performs Well vs Thermal Systems

News Conference News ESC 2023

ADVENT: Pulsed-Field Ablation for Paroxysmal AF Performs Well vs Thermal Systems

August 27, 2023

COP-AF: Colchicine Doesn’t Cut Post-Op AF or Myocardial Injury

News Conference News ESC 2023

COP-AF: Colchicine Doesn’t Cut Post-Op AF or Myocardial Injury

Michael O'Riordan

August 25, 2023

Pulsed-Field Ablation Cuts AF Recurrence at 1 Year: MANIFEST-PF Registry

News Conference News EHRA 2023

Pulsed-Field Ablation Cuts AF Recurrence at 1 Year: MANIFEST-PF Registry

Michael O'Riordan

April 25, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.